Curative Effect Evaluation of Shexiang Baoxin Pill on Coronary Artery Disease Not Amenable to Revascularization

Exclusion Criteria

• •Patients with severe valvular disease, congenital cardiomyopathy decompensation
• •Patients with CAD complicated with severe multiple organ disease such as severe heart failure, severe lung, liver or renal dysfunction, peptic ulcer in active stage, or intracranial hemorrhage
• •Patients that use high-dose steroids due to connective tissue disease
• •Patients with serious infections
• •Patients with malignant tumor
• •Patients with hematopoietic diseases
• •Pregnant or lactating women.